IFF

Last updated January 31, 2026

Innovation Areas

2,395

Inventors

Collaborations

Transdermal permeability enhancing matrix: IFFRecent Research Landscape

Uncontrolled molecular diffusion rates in transdermal patches lead to inconsistent dosage and poor bioavailability. This architecture utilizes an activated charcoal infusion to regulate the adsorption and release kinetics of exogenous molecules.

What technical problems is IFF addressing in Transdermal permeability enhancing matrix?

Inadequate dermal barrier penetration

(3)evidences

Standard topical applications suffer from poor adherence and inconsistent coverage against environmental stressors. Providing a stable delivery matrix prevents protection gaps and premature degradation of active ingredients on the skin surface.

Inadequate metabolic waste clearance

(1)evidences

Fluctuating delivery rates lead to sub-therapeutic or toxic levels. Maintaining steady-state concentrations ensures sustained efficacy and safety.